Scinovex
articleTop 1% cited

Oral Bisphosphonate-Induced Osteonecrosis: Risk Factors, Prediction of Risk Using Serum CTX Testing, Prevention, and Treatment

Journal of Oral and Maxillofacial Surgery · 2007 · Vol. 65(12) · pp. 2397–2410
César A. MiglioratiJoseph E. CilloJuan J. Ulloa
Bone health and treatmentsBone and Joint DiseasesOral health in cancer treatmentMedicineBisphosphonateOsteoporosisInternal medicineN-terminal telopeptideOsteonecrosis of the jawPrednisoneBone resorptionRelative riskOsteopenia

MeSH terms

Risedronic AcidDiphosphonatesFemaleHumansJaw DiseasesMiddle AgedOsteonecrosisPeptidesProspective StudiesEtidronic AcidTime FactorsBiomarkersAlendronateCollagen Type IBone Density Conservation Agents
Citations
715
FWCI
25.52
field-weighted impact
References
32
Percentile
100%
vs. same field & year
Citations per year
References
Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases
Journal of Oral and Maxillofacial Surgery · 2004 · 2,052 citations
Severely Suppressed Bone Turnover: A Potential Complication of Alendronate Therapy
The Journal of Clinical Endocrinology & Metabolism · 2005 · 1,422 citations
Nature and Frequency of Bisphosphonate-Associated Osteonecrosis of the Jaws in Australia
Journal of Oral and Maxillofacial Surgery · 2007 · 646 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.